Company Search:
Advanced Search
Sponsored Links
Immunodiagnostic System HDQ Company Snapshot
Immunodiagnostic System HDQ operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immunodiagnostic System HDQ with three other pharmaceutical manufacturers in Europe: Mithra Pharmaceuticals SA of Belgium (2017 sales of 46.25 million Euro [US$56.47 million] ), Diaxonhit SA of France (42.90 million Euro [US$52.38 million] ), and Moberg Pharma AB (publ) which is based in Sweden (439.03 million Swedish Kronor [US$51.53 million] ).

Sales Analysis. During the year ended March of 2017, sales at Immunodiagnostic System HDQ were £40.04 million (US$55.84 million). This is an increase of 4.5% versus 2016, when the company's sales were £38.31 million. Despite this increase, sales are still below the level achieved in 2015, when Immunodiagnostic System HDQ reported sales of £45.36 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Immunodiagnostic System HDQ
  Stock Performance Chart for Immunodiagnostic System HDQ
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 230.00p
(Figures in Pounds Sterling)
1 Week 0.0%   13 Weeks -2.5%  
4 Weeks -20.7%   52 Weeks -27.0%  
Immunodiagnostic System HDQ Key Data:
  Ticker: IDH Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 40,035,000
(Year Ending Jan 2018).
Employees: 275
  Currency: Pounds Sterling Market Cap: 67,659,392
  Fiscal Yr Ends: March Shares Outstanding: 29,417,127
  Share Type: Ordinary Closely Held Shares: 8,955,256
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.